Pola Pengobatan Pada Pasien Infark Miokard Akut Di Rumah Sakit Abdul Wahab Sjahranie Samarinda

Authors

  • Desta Winanda
  • Wisnu Cahyo Prabowo
  • Rolan Rusli Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia http://orcid.org/0000-0003-1264-5933

DOI:

https://doi.org/10.25026/mpc.v10i1.369

Keywords:

acute myocardial infarction, treatment patterns, characteristics

Abstract

Acute myocardial infarction is a major health problem that needs special attention because of the mortality prevalence and costs is quite high. Generally caused by plaque rupture and thrombus of coronary arteries so that the oxygen-containing blood supply is reduced to the myocardium. The purpose of this study was to determine the characteristics of acute myocardial infarction patients and acutemiokardial infarction drug use pattern at Abdul Wahab Sjahranie Hospital, Samarinda City in the January-December 2018 period. This study was a non-experimental study with a retrospective method and analyzed descriptively. Sampling using a purposive sampling method. The results of the most characteristic study were obtained in patients with acute myocardial infarction in men, namely 7,4%, age characteristics 46-55 years 37,1%, private work 48,6%, and high school education 47,1%. The most treatment pattern used in STEMI patients out of 32 patients was Nitrate + DAPT + Anticoagulant + ACE-I + Statin for 6 patients (18.7%) and the most treatment pattern used in NSTEMI patients out of 38 patients was Nitrate + DAPT + Anticoagulant + ß-Blocker + Statins in 7 patients (18.4%). The use of most drugs ISDN (antiangina) as much as 90%, morphine and petidine (potency analgesic) 8.6%, aspirin (antiplatelet) 84.3%, fondaparinuks (anticoagulants) 68.6% and streptokinase (fibrinolytic agents) 5.7% . To prevent reinfarction the most used drug is bisoprolol (ß-Blocker) 28.6%. The most commonly used left ventricular damage inhibitor candesartan (ARB) is 22.8%. The most given antidislipidemia was simvastatin 47.1%.

References

[1] Dipiro J.T., Wells B.G., Schwinghammer T.L. and DiPiro C. V. 2015. Pharmacotherapy Handbook. Ninth Edit. McGraw-Hill Education Companies. Inggris
[2] Dipiro, J.T., Talbert, H.L., Yee, G.C. Matzke, G.R., Wells, B.G. and Posey, L.M. 2011. Pharmacotherapy a Pathophysiologic Approach 8thed. The McGraw-Hill companies. New York.
[3] Dipiro J.T., Wells B.G., Schwinghammer T.L. and DiPiro C. V. 2015. Pharmacotherapy Handbook. Ninth Edit. McGraw-Hill Education Companies. Inggris.
[4] Hanafiah A. 2004. Angina Pektoris. Dalam : Rilantono LI, Baraas F, Karo SK, Roebiono PS, (eds), Buku Ajar Kardiologi. FKUI. Jakarta.
[5] Marley, J. 2000. Efficacy, Effectivenes, Eficiency, Department of General Practise. University of Adelaide. Adelaide. 23 (6) : 114-5.
[6] Notoatmodjo, S. 20l0. Promosi Kesehatan, teori dan aplikasi. Jakarta. PT Rineka Cipta.
[7] Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). 2015. Pedoman Tatalaksana Sindrom Koroner Akut. PERKI. Jakarta.
[8] Riset Kesehatan Dasar. 2013. Badan Penelitian dan Pengembangan Kesehatan. Departemen Kesehatan Republik Indonesia. Jakarta.
[9] Setianto B. 2009. Kejadian Kardiovaskuler Mayor pada Perempuan. Jurnal Kardiologi Indonesia. Vol 30 (13-14).
[10] Ulfah A. 2007. Penyakit Jantung Pada Perempuan. Jurnal Kardiologi Indonesia. Vol 28.
[11] Wagiu B. Mutiara, Janry A. Pangemanan, Agnes L. Panda. 2016. Hubungan Derajat Merokok dengan Kejadian Infark Miokard di RSUP Prof. Dr. R. D. Kandou Manado. Jurnal e-Clinic (eCl). Vol. 4, No. 2.

Downloads

Published

2019-10-31

How to Cite

Winanda, D., Prabowo, W. C., & Rusli, R. (2019). Pola Pengobatan Pada Pasien Infark Miokard Akut Di Rumah Sakit Abdul Wahab Sjahranie Samarinda. Proceeding of Mulawarman Pharmaceuticals Conferences, 10(1), 94–99. https://doi.org/10.25026/mpc.v10i1.369

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>